Contribution of non-traditional lipid profiles to reduced glomerular filtration rate in H-type hypertension population of rural China

Annals of Medicine
Haoyu WangYingxian Sun

Abstract

Despite current interest in the unfavourable impact of non-traditional lipid profiles on cardiovascular disease, information regarding its relations to reduced glomerular filtration rate (GFR) in H-type hypertension population has not been systemically elucidated. Analyses were based upon a cross-sectional study of 3259 participants with H-type hypertension who underwent assessment of biochemical, anthropometric and blood pressure values. Reduced GFR was considered if meeting estimated GFR <60 ml/min/1.73 m2. A stepwise multivariate regression analysis indicated that non-traditional lipid parameters remained as independent determinants of estimated GFR (all p < .001). In multivariable models, we observed a 50%, 51%, 31%, and 24% higher risk for decreased GFR with each SD increment in TC/HDL-C, TG/HDL-C, LDL-C/HDL-C ratios and non-HDL-C levels, respectively. The highest quartile of TC/HDL-C, TG/HDL-C and LDL-C/HDL-C ratios carried reduced GFR odds (confidence intervals) of 5.50 (2.50 to 12.09), 6.63 (2.58 to 17.05) and 2.22 (1.15 to 4.29), respectively. The relative independent contribution of non-traditional lipid profiles, as indexed by TC/HDL-C, TG/HDL-C, LDL-C/HDL-C ratios and non-HDL-C, towards reduced GFR putting research ...Continue Reading

References

Mar 1, 1990·Kidney International·B L KasiskeW F Keane
Jun 26, 1999·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·N D VaziriK Liang
Mar 10, 2001·Cell·C K Glass, J L Witztum
Jan 18, 2005·Lancet·Patricia M KearneyJiang He
Apr 21, 2005·Annals of Epidemiology·F BarziUNKNOWN Asia Pacific Cohort Studies Collaboration
Jan 13, 2006·American Journal of Physiology. Renal Physiology·N D Vaziri
Jun 10, 2006·Journal of the American Society of Nephrology : JASN·Sabrina SandhuMarcello Tonelli
Dec 13, 2006·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Gursharan DograGerald Watts
Aug 21, 2007·JAMA : the Journal of the American Medical Association·Erik IngelssonRamachandran S Vasan
Dec 7, 2007·Clinical Journal of the American Society of Nephrology : CJASN·Ian H de BoerBryan Kestenbaum
Apr 25, 2008·American Journal of Nephrology·Lorien S Dalrymple, George A Kaysen
May 6, 2008·Lancet·Carlene M M LawesUNKNOWN International Society of Hypertension
Jun 21, 2008·Journal of the American College of Cardiology·Charles R Harper, Terry A Jacobson
Aug 5, 2008·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Mahboob RahmanUNKNOWN ALLHAT Collaborative Research Group
May 6, 2009·Annals of Internal Medicine·Andrew S LeveyUNKNOWN CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration)
Mar 24, 2010·Nature Reviews. Nephrology·Nosratola D VaziriAlan M Fogelman
Jun 19, 2010·Clinical Journal of the American Society of Nephrology : CJASN·Varun ChawlaVandana Menon
Sep 3, 2010·Journal of the Neurological Sciences·Amytis TowfighiBruce Ovbiagele
Jan 14, 2011·Blood Purification·Nosratola D Vaziri, Keith Norris
Dec 21, 2012·Journal of Korean Medical Science·Ji-Young KimJae-Yong Shim
May 17, 2014·Clinical Journal of the American Society of Nephrology : CJASN·Mahboob RahmanUNKNOWN CRIC Study Investigators
Jul 31, 2014·International Journal of Environmental Research and Public Health·Liying ZhangHequn Zou
Jan 13, 2015·International Journal of Cardiology·Guo-Zhe SunYing-Xian Sun
Mar 17, 2015·JAMA : the Journal of the American Medical Association·Yong HuoUNKNOWN CSPPT Investigators
Jul 7, 2015·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Kazuhiko TsuruyaTsuyoshi Watanabe
Mar 10, 2016·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Zhongying ZhangXiang Gu
Mar 15, 2016·JAMA Internal Medicine·Sarah LewingtonUNKNOWN China Kadoorie Biobank Consortium
Apr 30, 2016·International Journal of Cardiology·Zhao LiAbraham Marria Roselle
Jul 1, 2016·Clinical and Experimental Hypertension : CHE·Zhilai ChenHuijun Liu
Jul 22, 2016·The Journal of Clinical Hypertension·Zengchun YeTanqi Lou
Aug 23, 2016·JAMA Internal Medicine·Xin XuUNKNOWN investigators of the Renal Substudy of the China Stroke Primary Prevention Trial (CSPPT)

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.